PepGen Inc
NASDAQ:PEPG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
PepGen Inc
NASDAQ:PEPG
|
US |
|
R
|
Road Environment Technology Co Ltd
SSE:688156
|
CN |
|
Z
|
Zooplus AG
F:ZO1
|
DE |
|
Deceuninck NV
LSE:0MEL
|
BE |
|
D
|
DNP Holding JSC
VN:DNP
|
VN |
|
Tycoons Group Enterprise Co Ltd
TWSE:2022
|
TW |
|
I
|
IG Group Holdings PLC
OTC:IGGRF
|
UK |
|
DiaSorin SpA
OTC:DSRLF
|
IT |
Multiples-Based Value
The Multiples-Based Value of one
PEPG
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 1.74 USD,
PepGen Inc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
PEPG Competitors Multiples
PepGen Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
PepGen Inc
NASDAQ:PEPG
|
119.8m USD | 0 | -1.3 | 0.3 | 0.3 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
380.1B USD | 6 | 88.3 | 14.7 | 20.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.4B USD | 5.1 | 24.2 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
174.1B USD | 5.9 | 20.3 | 12.7 | 15.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.6B USD | 9.3 | 28.2 | 21.1 | 22.1 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.2B USD | 5.5 | 17.7 | 13.1 | 14.9 | |
| AU |
|
CSL Ltd
ASX:CSL
|
68.5B AUD | 3.1 | 34 | 11.3 | 14.2 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.6B EUR | 11.3 | 36.2 | 39.3 | 40.1 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |